A. Stefani et al., THE MODULATION OF CALCIUM CURRENTS BY THE ACTIVATION OF MCLURS - FUNCTIONAL IMPLICATIONS, Molecular neurobiology, 13(1), 1996, pp. 81-95
Glutamatergic transmission in the central nervous system (CNS) is medi
ated by ionotropic, ligand-gated receptors (iGluRs), and metabotropic
receptors (mGluRs). mGluRs are coupled to GTP-binding regulatory prote
ins (G-proteins) and modulate different second messenger pathways. Mul
tiple effects have been described following their activation; among ot
hers, regulation of fast synaptic transmission, changes in synaptic pl
asticity, and modification of the threshold for seizure generation. So
me of the major roles played by the activation of mGluRs might depend
on the modulation of high-voltage-activated (HVA) calcium (Ca2+) curre
nts. Some HVA Ca2+ channels (N-, P-, and Q-type channels) are signalin
g components at most presynaptic active zones. Their mGluR-mediated in
hibition reduces synaptic transmission. The interference, by agonists
at mGluRs, on L-type channels might affect the repetitive neuronal fir
ing behavior and the integration of complex events at the somatic leve
l. In addition, the mGluR-mediated effects on voltage-gated Ca2+ signa
ls have been suggested to strongly influence neurotoxicity. Rather dif
ferent coupling mechanisms underlie the relation between mGluRs and Ca
2+ currents: Together with a fast, membrane-delimited mechanism of act
ion, much slower responses, involving intracellular second messengers,
have also been postulated. In the recent past, the relative paucity o
f selective agonists and antagonists for the different subclasses of m
GluRs had hampered the clear definition of the roles of mGluRs in brai
n function. However, the recent availability of new pharmacological to
ols is promising to provide a better understanding of the neuronal fun
ctions related to different mGluR subtypes. The analysis of the mGluR-
mediated modulation of Ca2+ conductances will probably offer new insig
hts into the characterization of synaptic transmission and the develop
ment of neuroprotective agents.